Aimen Waqar Khan, Mishal Abid, & Sameer Abdul Rauf. (2023). Limitations in FABP4 as a biomarker for diabetic nephropathy: A critique of Shaker et al. SpringerOpen.
Chicago Style (17th ed.) CitationAimen Waqar Khan, Mishal Abid, and Sameer Abdul Rauf. Limitations in FABP4 as a Biomarker for Diabetic Nephropathy: A Critique of Shaker Et Al. SpringerOpen, 2023.
MLA (9th ed.) CitationAimen Waqar Khan, et al. Limitations in FABP4 as a Biomarker for Diabetic Nephropathy: A Critique of Shaker Et Al. SpringerOpen, 2023.
Warning: These citations may not always be 100% accurate.